Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Phone Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Phone Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Indian drugmaker to produce 200mn doses of Russia's Sputnik V
  • World

    Indian drugmaker to produce 200mn doses of Russia's Sputnik V

    Sagar Malik
    Written by
    Sagar Malik
    Twitter
    Last updated on Mar 19, 2021, 05:48 pm
    Indian drugmaker to produce 200mn doses of Russia's Sputnik V
  • Stelis Biopharma, the biopharmaceutical arm of Bengaluru-based Strides Pharma Science, will be making and supplying at least 200 million doses of the Sputnik V vaccine, the Russian coronavirus vaccine currently awaiting emergency use approval in India.

    This makes India one of the biggest producers of Sputnik V, outside of Russia.

    Here are more details on this.

  • In this article
    Stelis to commence supplies later this year Deal will 'widen access to vaccine on a global scale' India capable of making 550mn Sputnik V doses a year Sputnik V awaiting emergency use approval in India
  • Details

    Stelis to commence supplies later this year

  • For this deal, Stelis has partnered with the Russian Direct Investment Fund (RDIF), which backed the development of Sputnik V.

    The company intends to commence supplies of the vaccine from the July-September quarter of 2021.

    "Stelis will also continue to work with the RDIF to provide additional supply volumes beyond the initial agreement," the Russian fund has said.

  • Statement

    Deal will 'widen access to vaccine on a global scale'

    Deal will 'widen access to vaccine on a global scale'
  • About the deal, Arun Kumar, founder of Strides Group, said, "We are delighted to partner with RDIF to make a substantial contribution toward providing global supply of the Sputnik V vaccine which is one of the most efficacious approved vaccines commercially available."

    Significant volumes will be produced to help "widen access to the vaccine on a global scale," said Kirill Dmitriev of RDIF.

  • Details

    India capable of making 550mn Sputnik V doses a year

    India capable of making 550mn Sputnik V doses a year
  • Sputnik V, developed by Moscow's Gamaleya Research Institute of Epidemiology and Microbiology, is said to have an efficacy of 91.6%.

    The latest agreement is expected to increase India's capacity to make this vaccine to around 550 million doses per year.

    Earlier, Hyderabad-based Gland Pharma had announced a similar partnership to produce up to 252 million doses of Sputnik V.

  • India

    Sputnik V awaiting emergency use approval in India

  • Meanwhile, Dr. Reddy's Laboratories is also working with the RDIF to conduct domestic clinical trials of the Sputnik V vaccine.

    It had also sought emergency use authorization last month but the Indian drug regulator asked it to furnish immunogenicity data.

    India has so far approved two COVID-19 vaccines - Bharat Biotech-developed COVAXIN and Serum Institute of India-manufactured Covishield.

  • Coronavirus
  • Russian Direct Investment Fund
  • Sputnik V
  •  
Latest News
  • Coronavirus: India reports biggest single-day spike with 1.1L new cases
    Coronavirus: India reports biggest single-day spike with 1.1L new cases
    India
  • NewsBytes Briefing: Mark Zuckerberg gives off mixed Signals, and more
    NewsBytes Briefing: Mark Zuckerberg gives off mixed Signals, and more
    Science
  • DC fans now campaigning for #DeathstrokeHBOMax, actor Joe Manganiello joins
    DC fans now campaigning for #DeathstrokeHBOMax, actor Joe Manganiello joins
    Entertainment
  • Realme 8's first update brings camera and touch improvements
    Realme 8's first update brings camera and touch improvements
    Science
  • Samsung Galaxy F41 receives One UI 3.1 update in India
    Samsung Galaxy F41 receives One UI 3.1 update in India
    Science
Trending Topics
Coronavirus
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News YouTube Hollywood News WhatsApp Bollywood News ISRO Elon Musk Yoga Honda Batman
Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Apple Royal Challengers Bangalore Toyota Fashion Tips
Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar Chris Morris
Big Bang Theory X-Men TATA Royal Enfield
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021